Ciresthel Bello Rios

Dr. Ciresthel Bello Rios

Laboratorio de Biomedicina Molecular-Universidad Autónoma de Guerrero
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Ciresthel Bello RiosCiresthel Bello Rios
Ciresthel Bello Rios
SMSarita Montaño
Sarita Montaño
OGOlga Lilia Garibay-Cerdenares
Olga Lilia Garibay-Cerdenares
LALilian Esmeralda Araujo-Arcos
Lilian Esmeralda Araujo-Arcos
MVMarco Antonio Leyva Vazquez
Marco Antonio Leyva Vazquez
BIBerenice Illades-Aguiar
Berenice Illades-Aguiar
The oncogenic potential of high-risk human papillomavirus (HPV) is predicated on the production of the E6 and E7 oncoproteins, which are responsible for disrupting the control of the cell cycle. Epidemiological studies have proposed that the presence of the N29S and H51N variants of the HPV16 E7 protein is significantly associated with cervical cancer. It has been suggested that changes in the amino acid sequence of E7 variants may affect the oncoprotein 3D structure; however, this remains uncertain. An analysis of the structural differences of the HPV16 E7 protein and its variants (N29S and H51N) was performed through homology modeling and structural refinement by molecular dynamics simulation. We propose, for the first time, a 3D structure of the E7 reference protein and two of Its variants (N29S and H51N), and conclude that the mutations induced by the variants in N29S and H51N have a significant influence on the 3D structure of the E7 protein of HPV16, which could be related to the oncogenic capacity of this protein.

29 June 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
VSVictoria SanchezMeza
Victoria SanchezMeza
Ciresthel Bello RiosCiresthel Bello Rios
Ciresthel Bello Rios
JEJosimar Eloy
Josimar Eloy
Yazmín Gómez-GómezYazmín Gómez-Gómez
Yazmín Gómez-Gómez
MVMarco Antonio Leyva Vazquez
Marco Antonio Leyva Vazquez
BIBerenice Illades-Aguiar
Berenice Illades-Aguiar
The E6 and E7 oncoproteins of high-risk types of human papillomavirus (HR-HPV) are crucial for the development of cervical cancer (CC). Small interfering RNAs (siRNAs) are explored as novel therapies that silence these oncogenes, but their clinical use is hampered by inefficient delivery systems. Modification (pegylation) with polyethylene glycol (PEG) of liposomal siRNA complexes (siRNA lipoplexes) may improve systemic stability. We studied the effect of siRNA targeting HPV16 E6, delivered via cationic liposomes (lipoplexes), on cellular processes in a cervical carcinoma cell line (CaSki) and its potential therapeutic use. Lipoplexes-PEG-HPV16 E6, composed of DOTAP, Chol, DOPE, and DSPE-PEG2000 were prepared. The results showed that pegylation (5% DSPE-PEG2000) provided stable siRNA protection, with a particle size of 86.42 ± 3.19 nm and a complexation efficiency of over 80%; the siRNA remained stable for 30 days. These lipoplexes significantly reduced HPV16 E6 protein levels and restored p53 protein expression, inhibiting carcinogenic processes such as proliferation by 25.74%, migration (95.7%), and cell invasion (97.8%) at concentrations of 20 nM, 200 nM, and 80 nM, respectively. In conclusion, cationic lipoplexes-PEG-HPV16 E6 show promise as siRNA carriers for silencing HPV16 E6 in CC.

20 October 2023 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Closed access
EAErnesto Andrade‐Collantes
Ernesto Andrade‐Collantes
BLBruno Landeros‐Rivera
Bruno Landeros‐Rivera
Yudibeth Sixto-LópezYudibeth Sixto-López
Yudibeth Sixto-López
Ciresthel Bello RiosCiresthel Bello Rios
Ciresthel Bello Rios
JCJulia Contreras-Garcia
Julia Contreras-Garcia
SMSarita Montaño
Sarita Montaño

25 December 2020 in Preprints.org
Verified
Preprint
Open access
Ciresthel Bello RiosCiresthel Bello Rios
Ciresthel Bello Rios
SMSarita Montaño
Sarita Montaño
OGOlga Lilia Garibay-Cerdenares
Olga Lilia Garibay-Cerdenares
LALilian Esmeralda Araujo-Arcos
Lilian Esmeralda Araujo-Arcos
MLMarco Antonio Leyva-Vázquez
Marco Antonio Leyva-Vázquez
BIBerenice Illades-Aguiar
Berenice Illades-Aguiar
The oncogenic potential of high-risk HPVs is focused on producing the E6 and E7 oncoproteins responsible for disrupting the control of the cell cycle. Epidemiological studies propose the presence of the N29S and H51N variants of the HPV16 E7 protein as a significant association with cervical cancer. It has been suggested that changes in the amino acid sequence of E7 variants may affect the oncoprotein 3D structure; however, this remains unknown. Analysis of the structural differences of the HPV16 E7 protein and its variants (N29S and H51N) was performed through homology modeling and structural refinement by molecular dynamics simulation. We propose for the first time a 3D structure of the E7 reference protein and two of its variants (N29S and H51N) and conclude that the mutations induced by the variants in N29S and H51N have a significant influence on the 3D structure of the E7 protein of HPV16, which could be related to the oncogenic capacity of this protein.

15 November 2022 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
Yazmín Gómez-GómezYazmín Gómez-Gómez
Yazmín Gómez-Gómez
Jorge Organista-NavaJorge Organista-Nava
Jorge Organista-Nava
SCSayuri Itzel Clemente-Periván
Sayuri Itzel Clemente-Periván
ALAlfredo Lagunas-Martínez
Alfredo Lagunas-Martínez
ESEric Genaro Salmerón-Bárcenas
Eric Genaro Salmerón-Bárcenas
BIBerenice Illades-Aguiar
Berenice Illades-Aguiar

17 January 2026 in Cell Biochemistry and Biophysics
Verified
Journal Article
Closed access
PDF file
LALilian Esmeralda Araujo-Arcos
Lilian Esmeralda Araujo-Arcos
SMSarita Montaño
Sarita Montaño
Ciresthel Bello RiosCiresthel Bello Rios
Ciresthel Bello Rios
OGOlga Lilia Garibay-Cerdenares
Olga Lilia Garibay-Cerdenares
MVMarco Antonio Leyva Vazquez
Marco Antonio Leyva Vazquez
BIBerenice Illades-Aguiar
Berenice Illades-Aguiar